Search

Returning search results with filters:

Category: Drugs Clear all

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 15 of 598 items.

Health alert or recall Unauthorized products may pose serious health risks
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…
AlertPublic advisory | 2022-05-25
Health alert or recall PMS-Montelukast: impurity
Presence of an unspecified impurity near the acceptable concentration limit in the affected lot.
RecallHealth product recall | 2022-05-19
Health alert or recall Leucovorin Calcium Injection: Out of Specification
The assay is out of specification in the affected lot(s).
RecallHealth product recall | 2022-05-13
Health alert or recall Advanced Relief Eye Drops: product safety
The complaint bottle contains Naphazolin HCl 0.013% and Glycern 0.26%. 
RecallHealth product recall | 2022-05-09
Health alert or recall One lot of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops recalled because of a packaging error that may pose health risks
Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…
AlertPublic advisory | 2022-05-07
Health alert or recall AA-FENO-SUPER: Product Quality
Presence of one (1) AA-FENO-SUPER 100 mg tablet in affected lot of AA-FENO-SUPER 160 mg.
RecallHealth product recall | 2022-05-05
Health alert or recall Apo-Acyclovir Tablets: NDMA impurity
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2022-04-28
Health alert or recall Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level. Apo-Acyclovir is a…
AlertPublic advisory | 2022-04-28
Health alert or recall Unauthorized health products seized from three herbal medicine stores in Calgary, Alberta
Health Canada is warning consumers not to use unauthorized health products seized from three herbal medicine stores in Calgary, Alberta, because they are labelled to contain prescription drugs and may pose serious health risks. The products include skin…
AlertPublic advisory | 2022-04-22
Health alert or recall Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…
AlertPublic advisory | 2022-04-21
Health alert or recall Accupril Tabs: Nitrosamine impurity
Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-04-20
Health alert or recall EyEnvy Eyelash & Eyebrow conditioner: unlicensed product with ingredient on prescription drug list.
All lots contain undeclared Isopropyl Cloprostenate that is listed on the prescription drug list.
RecallHealth product recall | 2022-04-19
Health alert or recall Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
Health alert or recall Accidental ingestion of illegal “copycat” edible cannabis products causing serious harm to children
Health Canada is reminding Canadians of the risk of serious harm if children accidentally consume edible cannabis. Health Canada is aware of several cases of children being hospitalized, particularly after consuming products that are illegal and…
AlertPublic advisory | 2022-04-08
Health alert or recall NETSPOT: Out of Specification
The Vial 1 assay may be out of specification in the affected lot(s).
RecallHealth product recall | 2022-03-24
Report a problem or mistake on this page
What was wrong?

You will not receive a reply. Telephone numbers and e-mail addresses will be removed.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.